EUVIMEDEUVIMED entdecken
Crossref

Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids

M H Lee, A C Sartorelli

Cancer Drug Delivery · 1983

DOI: 10.1089/cdd.1983.1.21 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Drug Delivery, 1983. Verfasst von M H Lee und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAzacitidineCell LineCholineClostridiumCytarabineLeukemia L1210Membrane LipidsMiceMicroscopy, Electron, ScanningSarcoma 180Type C Phospholipases

Substanzen

Membrane LipidsCytarabineType C PhospholipasesAzacitidineCholine

Förderung

  • NCI NIH HHS

Zitieren

APA

Lee, M. H., & Sartorelli, A. C. (1983). Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids. Cancer Drug Delivery. https://doi.org/10.1089/cdd.1983.1.21

Vancouver

Lee MH, Sartorelli AC. Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids. Cancer Drug Delivery. 1983. doi:10.1089/cdd.1983.1.21

BibTeX
@article{Lee1983,
  author = {Lee, M H and Sartorelli, A C},
  title = {Combination Chemotherapy with Clostridium perfringens Phospholipase C and Cytosine Antimetabolites: Complementary Inhibition Directed at Membrane Lipids},
  journal = {Cancer Drug Delivery},
  year = {1983},
  doi = {10.1089/cdd.1983.1.21}
}
Kostenlos starten →